Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19
Phase 3
Completed
- Conditions
- Health Condition 1: B342- Coronavirus infection, unspecified
- Registration Number
- CTRI/2020/04/024659
- Lead Sponsor
- SSV Phytopharmaceuticals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. Recent history of contact with COVID-19 positive people and are advised to be quarantined or has symptoms which include cough, fever with or without chills and difficulty in breathing.
2. Willing to provide informed consent.
Exclusion Criteria
1. Presence of acute hypoxic respiratory failure.
2. Intensive care unit (ICU) stay.
3. Patients who need mechanical ventilation.
4. Category 6 or 5 based on modified 7-category ordinal scale of clinical status.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method